Andale, Genelyn A.
HRN: 24-18-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2023
CEFUROXIME 1.5GM (VIAL)
11/30/2023
12/07/2023
IV
1.5g
Q8H
Fracture, Abrasions
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes